Latest Nutrition News

30Nov
2022

Fatal Drug Overdoses Among U.S. Seniors Have Tripled Since 2000

Fatal Drug Overdoses Among U.S. Seniors Have Tripled Since 2000WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- Growing numbers of older Americans are dying from drug overdoses and alcohol abuse.That's the tragic takeaway from two new reports by the U.S. Centers for Disease Control and Prevention.More than 5,000 people aged 65 and older in the United States died of a drug overdose in 2020, and this number has tripled since 2000, according to one of the reports.The other report revealed that more than 11,600 U.S. seniors died from alcohol-induced causes in 2020. Alcohol-induced death rates in this age group have been on the rise since 2011 and jumped more than 18% from 2019 to 2020.The new research wasn’t designed to look at why more older Americans are dying from drug overdoses or alcohol abuse, but the findings mirror what has been seen in younger...

Black Patients Fare Worse Than White Patients After...

30 November 2022
Black Patients Fare Worse Than White Patients After Angioplasty, StentsWEDNESDAY, Nov. 30, 2022 (HealthDay News) -- Black adults who undergo a common procedure to open up clogged arteries are readmitted to the hospital more often than their white peers. They're also more likely to die in the years after treatment, a new study finds.Researchers looked at how patients fared following balloon angioplasty and coronary stenting -- "one of the most common cardiovascular procedures performed in the U.S.," said study co-author Dr. Devraj Sukul."We found significant differences in post-discharge outcomes such as readmission and long-term mortality," said Sukul, an interventional cardiologist at the University of Michigan.The minimally invasive treatment is routinely offered to adults diagnosed with a narrowing of the coronary arteries. Doctors use a balloon to...

AHA News: As Winter Approaches, Seasonal Depression May...

30 November 2022
AHA News: As Winter Approaches, Seasonal Depression May Set in for MillionsWEDNESDAY, Nov. 30, 2022 (American Heart Association News) -- Winter's coming. The leaves have fallen, temperatures are dropping and there's less daylight to brighten our moods.While some enjoy the changing of the seasons, millions of U.S. adults will experience a form of depression during the winter months known as seasonal affective disorder, or SAD. It can feel just like regular depression, because it is, said Thea Gallagher, a clinical assistant professor in the department of psychiatry at New York University Grossman School of Medicine/NYU Langone in New York City."The only difference is the onset of this depression coordinates with the seasons," she said. "It usually starts in fall and winter when there is less light, less activity, colder temperatures and a changing schedule....

Shortages of Antibiotics, Antivirals Are Making a Tough...

30 November 2022
Shortages of Antibiotics, Antivirals Are Making a Tough Illness Season WorseWEDNESDAY, Nov. 30, 2022 (HealthDay News) -- An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report.The antiviral flu drug Tamiflu is in short supply for both adults and children, in both its brand name formulation as well as the generic version, said Michael Ganio, senior director of pharmacy practice and quality with the American Society of Health-System Pharmacists.In addition, shortages are occurring in the pediatric versions of amoxicillin and Augmentin, two antibiotics used to treat bacterial infections that often follow flu, RSV (respiratory syncytial virus) or COVID in children, said Brigid Groves, senior director of practice and professional affairs with the American...

Experimental Alzheimer's Drug May Slow Decline, But Safety Concerns Linger

30 November 2022
Experimental Alzheimer`s Drug May Slow Decline, But Safety Concerns LingerWEDNESDAY, Nov. 30, 2022 (HealthDay News) -- The experimental Alzheimer's drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain.In the eagerly awaited trial findings, published Tuesday in the New England Journal of Medicine, researchers reported that lecanemab “reduced brain amyloid levels and was associated with moderately less decline on clinical measures of cognition and function than placebo at 18 months, but was associated with adverse events."The bottom line, according to the researchers: "Longer trials are warranted to determine the efficacy and safety of lecanemab in early Alzheimer’s disease.”Exactly how much difference did the drug, made by Eisai...
RSS
1345678910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.